1.2BUSD
0.83
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US12648L6011
CUSIP
150934404
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
-0.19
Dividend Share
0
Dividend Yield
0.00%
Earnings Share
-0.54
Wall Street Target Price
10.37
EPS Estimate Current Year
-0.31
EPS Estimate Next Year
0.09
EPS Estimate Current Quarter
-0.12
EPS Estimate Next Quarter
-0.09
Most Recent Quarter
-
Revenue TTM
75,769,000
Gross Profit TTM
50,434,000
EBITDA
-53,565,000
Profit Margin
-91.38%
Return On Assets TTM
-28.58%
Return On Equity TTM
-1018.75%
Revenue Per Share TTM
0.618
Qtly Revenue Growth YOY
950.80%
Diluted Eps TTM
-0.54
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
26
Price Sales TTM
22.0081
Price Book MRQ
112.6329
Enterprise Value Revenue
20
Enterprise Value EBITDA
-6
33.98
3.61%69.82
2.74%3.22
1.26%112.83
0.83%557.00
0.81%480.60
0.35%152.39
-5.05%80.00
-0.68%6.38
-0.31%228.74
-0.07%